Stasis ulcers refractory to therapy--accelerated healing by treatment with clopidogrel +/- dalteparin: a preliminary report

Clin Appl Thromb Hemost. 2001 Jan;7(1):21-4. doi: 10.1177/107602960100700105.

Abstract

Stasis ulcers are commonly the result of chronic venous insufficiency. We have recently assessed 15 patients with stasis ulcers that failed to heal after one year of routine wound care. All patients demonstrated a defect in hemostasis, and a biopsy revealed livido vasculitis. Eleven of fifteen patients were treated with clopidogrel and dalteparin, and 4 of 15 patients were treated with clopidogrel alone. Thirteen of fifteen patients (86.6%) completely healed within three months of starting antithrombotic therapy. Patients with stasis ulcers and chronic venous insufficiency who fail to heal with routine wound care should be subjected to biopsy, a procoagulant defect evaluation, and initiation of clopidogrel and dalteparin therapy if a defect is found.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anticoagulants / administration & dosage
  • Anticoagulants / standards
  • Antiphospholipid Syndrome / complications
  • Clopidogrel
  • Dalteparin / administration & dosage*
  • Dalteparin / standards
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / standards
  • Thrombophilia / blood
  • Thrombophilia / complications
  • Ticlopidine / administration & dosage*
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / standards
  • Treatment Outcome
  • Varicose Ulcer / blood*
  • Varicose Ulcer / drug therapy*
  • Varicose Ulcer / etiology
  • Venous Thrombosis / complications

Substances

  • Anticoagulants
  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine
  • Dalteparin